Longest UN climate talks end
Marathon international climate talks ended on 15 December 2019 with negotiators postponing until next year a key decision on how to regulate global carbon markets.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/22345-longest-un-climate-talks-end.html
#COP25 #LongestUN #climatetalks #Madrid #Glasgow #greenhousegas

India in CCPI 2020
India is among the top 10 nations as per the Climate Change Performance Index (CCPI) which is based parameters like renewable power and energy use efficiency, Power Minster R K Singh said.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/22344-india-in-ccpi-2020.html
#CCPI2020 #India #RKSingh #COP #NDCs #CCPI

Khyber Pass economic agreement
Pakistan and the World Bank has signed a project agreement worth $406.6 million for financing the Khyber Pass Economic Corridor (KPEC) project with an aim to promote economic development.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/22343-khyber-pass-economic-agreement.html
#Khyber #KPEC #WorldBank #Pakistan

MCA's 2019 Review
In its year-end review, the Ministry of Corporate Affairs (MCA) on 15 December 2019 mentioned the various steps it undertook in 2019 for ease of doing business and creating a robust insolvency framework.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/22342-mca-s-2019-review.html
#MCA #SPICe #NCLT #CCI #DVRs #WorldBank #GreenChannel #Amendment

Draft guidelines to treat rare genetic diseases
In a bid to attract the pharmaceutical industry for pooling investments in drugs for treating rare diseases, country’s apex research body Indian Council of Medical Research (ICMR) has come up with national guidelines for gene therapy related clinical trials.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/22341-draft-guidelines-to-treat-rare-genetic-diseases.html
#ICMR #PID #CDSCO #NDCTR #India #CAGR #orphandrug

WHO Named 2019-nCoV
The UN health agency on February 11 announced that "COVID-19" will be the official name of the deadly virus disease from China, saying the disease represented a "very grave threat" for the world but there was a "realistic chance" of stopping it.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/22842-who-named-2019-ncov.html
#WHO #CoV #COVID #NCP #WHO #MERS #SARS

India is ineligible for GSP benefits: USTR
The United States Trade Representative’s (USTR) office has classified India as a developed economy, ineligible for benefits given by Washington DC to developing countries.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/22841-india-is-ineligible-for-gsp-benefits-ustr.html
#India #GSP #USTR #GNI #America #PiyushGoyal

Andhra's proposal under PM-KISAN rejected
The Centre has rejected Andhra Pradesh government’s proposal to release the payment under PM-KISAN scheme as a lumpsum amount instead of installments, Agriculture Minister Narendra Singh Tomar informed Parliament on 11 February 2020.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/22840-andhra-s-proposal-under-pm-kisan-rejected.html
#Andhra #PMKISAN #NarendraSinghTomar #SMFs

Section 3 of the Drugs and Cosmetics Act notified
To ensure that all medical devices meet certain standards of quality and efficacy, the Union Health Ministry on 11 February 2020 notified medical equipment used on humans or animals as "drugs" under Section 3 of the Drugs and Cosmetics Act, with effect from April 1, 2020.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/22839-section-3-of-the-drugs-and-cosmetics-act-notified.html
#Section3 #CosmeticsAct #Drugs #CDSCO #DTAB #MaliniAisola